Search by Drug Name or NDC

NDC 00363-0134-78 Guaifenesin and Pseudoephedrine HCl 1200; 120 mg/1; mg/1 Details

Guaifenesin and Pseudoephedrine HCl 1200; 120 mg/1; mg/1

Guaifenesin and Pseudoephedrine HCl is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by WALGREEN CO.. The primary component is GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

Related Packages: 00363-0134-78
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin

Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.

Related Packages: 00363-0134-78
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pseudoephedrine

Product Information

NDC	00363-0134
Product ID	0363-0134_f328fc61-c015-4a7d-8f28-5f7d6e80f326
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Guaifenesin and Pseudoephedrine HCl
Proprietary Name Suffix	n/a
Non-Proprietary Name	Guaifenesin and Pseudoephedrine HCl
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	1200; 120
Active Ingredient Units	mg/1; mg/1
Substance Name	GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
Labeler Name	WALGREEN CO.
Pharmaceutical Class	Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA213203
Listing Certified Through	2024-12-31

Package

NDC 00363-0134-78 (00363013478)

Pricing Information	N/A
NDC Package Code	0363-0134-78
Billing NDC	00363013478
Package	2 BLISTER PACK in 1 CARTON (0363-0134-78) / 12 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Marketing Start Date	2020-08-05
NDC Exclude Flag	N